Zai Historical Financial Ratios
| ZLAB Stock | USD 29.20 0.35 1.21% |
Zai Lab is currently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0, PTB Ratio of 0.34 or Days Sales Outstanding of 130 will help investors to properly organize and evaluate Zai Lab financial condition quickly.
Zai |
About Zai Financial Ratios Analysis
Zai LabFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Zai Lab investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Zai financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Zai Lab history.
Zai Lab Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Zai Lab stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Zai Lab sales, a figure that is much harder to manipulate than other Zai Lab multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Zai Lab's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Zai Lab current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.At present, Zai Lab's PTB Ratio is projected to slightly grow based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 130.04, whereas Price To Sales Ratio is forecasted to decline to 0.91.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.41 | 1.12 | 0.85 | 0.89 | Days Of Inventory On Hand | 132.41 | 155.93 | 170.76 | 249.78 |
Zai Lab fundamentals Correlations
Click cells to compare fundamentals
Zai Lab Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zai Lab fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 38.8 | 21.17 | 4.18 | 1.4 | 0.96 | 0.91 | |
| Ptb Ratio | 1.71 | 0.89 | 0.44 | 0.29 | 0.32 | 0.34 | |
| Days Sales Outstanding | 106.56 | 38.51 | 138.63 | 82.44 | 89.41 | 130.04 | |
| Book Value Per Share | 4.58 | 15.06 | 14.84 | 10.91 | 8.24 | 5.48 | |
| Free Cash Flow Yield | (0.41) | (0.22) | (0.94) | (1.3) | (0.81) | (0.85) | |
| Operating Cash Flow Per Share | (2.97) | (2.78) | (5.91) | (3.84) | (2.05) | (2.15) | |
| Capex To Depreciation | 4.05 | 2.3 | 2.92 | 3.04 | 0.94 | 0.89 | |
| Pb Ratio | 1.71 | 0.89 | 0.44 | 0.29 | 0.32 | 0.34 | |
| Ev To Sales | 34.63 | 12.52 | (2.39) | (3.19) | (1.95) | (1.85) | |
| Free Cash Flow Per Share | (3.2) | (2.92) | (6.11) | (4.1) | (2.14) | (2.25) | |
| Roic | (0.64) | (0.29) | (0.5) | (0.42) | (0.46) | (0.44) | |
| Inventory Turnover | 0.62 | 1.27 | 2.76 | 2.34 | 2.14 | 3.76 | |
| Net Income Per Share | (2.85) | (3.84) | (7.45) | (5.03) | (3.46) | (3.64) | |
| Days Of Inventory On Hand | 584.67 | 286.66 | 132.41 | 155.93 | 170.76 | 249.78 | |
| Payables Turnover | 0.17 | 0.27 | 0.41 | 1.12 | 0.85 | 0.89 | |
| Research And Ddevelopement To Revenue | 10.95 | 4.55 | 3.97 | 1.33 | 1.0 | 0.95 | |
| Capex To Revenue | 1.17 | 0.22 | 0.13 | 0.12 | 0.0318 | 0.0302 | |
| Cash Per Share | 4.29 | 15.28 | 15.15 | 10.53 | 8.34 | 7.07 | |
| Pocfratio | (2.64) | (4.8) | (1.1) | (0.82) | (1.29) | (1.36) | |
| Capex To Operating Cash Flow | (0.0798) | (0.0494) | (0.0345) | (0.068) | (0.0428) | (0.045) | |
| Pfcf Ratio | (2.44) | (4.57) | (1.06) | (0.77) | (1.24) | (1.3) | |
| Days Payables Outstanding | 2.2K | 1.4K | 881.52 | 325.33 | 430.43 | 408.9 | |
| Income Quality | 0.98 | 0.8 | 0.78 | 0.83 | 0.59 | 0.61 | |
| Roe | (0.62) | (0.25) | (0.5) | (0.46) | (0.42) | (0.4) | |
| Ev To Operating Cash Flow | (2.35) | (2.84) | 0.63 | 1.87 | 2.62 | 2.75 | |
| Pe Ratio | (2.75) | (3.48) | (0.87) | (0.63) | (0.77) | (0.8) | |
| Return On Tangible Assets | (0.53) | (0.23) | (0.43) | (0.4) | (0.33) | (0.34) | |
| Ev To Free Cash Flow | (2.18) | (2.7) | 0.61 | 1.75 | 2.51 | 2.64 | |
| Earnings Yield | (0.36) | (0.29) | (1.15) | (1.6) | (1.31) | (1.37) | |
| Intangibles To Total Assets | 0.0248 | 0.007275 | 0.006 | 0.006887 | 0.0159 | 0.0167 | |
| Net Debt To E B I T D A | 0.27 | 1.61 | 1.38 | 2.57 | 2.12 | 1.42 | |
| Current Ratio | 6.27 | 12.4 | 7.78 | 8.04 | 4.63 | 4.4 | |
| Tangible Book Value Per Share | 4.44 | 14.93 | 14.74 | 10.83 | 8.07 | 5.42 | |
| Receivables Turnover | 3.43 | 9.48 | 2.63 | 4.43 | 4.08 | 3.4 | |
| Graham Number | 17.13 | 36.06 | 49.86 | 35.15 | 25.33 | 20.99 | |
| Shareholders Equity Per Share | 4.58 | 15.06 | 14.84 | 10.91 | 8.24 | 5.48 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 3.647 | Quarterly Revenue Growth 0.477 | Return On Assets (0.21) | Return On Equity (0.35) |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.